Novel olanzapine analogues presenting a reduced H1 receptor affinity and retained 5HT2A/D2 binding affinity ratio.
about
Novel olanzapine analogues presenting a reduced H1 receptor affinity and retained 5HT2A/D2 binding affinity ratio.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Novel olanzapine analogues pre ...... T2A/D2 binding affinity ratio.
@ast
Novel olanzapine analogues pre ...... T2A/D2 binding affinity ratio.
@en
Novel olanzapine analogues pre ...... T2A/D2 binding affinity ratio.
@nl
type
label
Novel olanzapine analogues pre ...... T2A/D2 binding affinity ratio.
@ast
Novel olanzapine analogues pre ...... T2A/D2 binding affinity ratio.
@en
Novel olanzapine analogues pre ...... T2A/D2 binding affinity ratio.
@nl
prefLabel
Novel olanzapine analogues pre ...... T2A/D2 binding affinity ratio.
@ast
Novel olanzapine analogues pre ...... T2A/D2 binding affinity ratio.
@en
Novel olanzapine analogues pre ...... T2A/D2 binding affinity ratio.
@nl
P2860
P50
P356
P1433
P1476
Novel olanzapine analogues pre ...... HT2A/D2 binding affinity ratio
@en
P2093
Marc E Bouillon
Somayeh Jafari
P2860
P2888
P356
10.1186/1471-2210-12-8
P577
2012-06-22T00:00:00Z
P5875
P6179
1037033236